Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: Effect of age, gender, and genetic background

Journal of Clinical Gastroenterology

Volumn 42, Issue 3, 2008, Pages 300-305

  Bittencourt, Paulo Lisboa ^a   Farias, Alberto Queiroz ^a   Porta, Gilda ^a   Cançado, Eduardo L R ^a   Miura, Irene ^a   Pugliese, Renata ^a   Kalil, Jorge ^a   Goldberg, Anna C ^a   Carrilho, Flair J ^a  

^a NONE

Author keywords

Autoantibodies; Autoimmune diseases; Autoimmune hepatitis; CTLA 4; HLA antigens; TNF

Indexed keywords

ACTIN ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BRAZIL; CHILD; CONCURRENT AUTOIMMUNE DISORDER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EXON; FEMALE; FREQUENCY ANALYSIS; GROUPS BY AGE; HLA TYPING; HUMAN; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOANTIBODIES; BRAZIL; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS, AUTOIMMUNE; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; INCIDENCE; INFANT; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; THYROIDITIS, AUTOIMMUNE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39749118629     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31802dbdfc     Document Type: Article

References (39)

1. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354:54-66.
2. Czaja AJ, Bianchi FB, Carpenter HA, et al. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology. 2005;41:207-215.
3. Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology. 2006;43:S132-S144.
4. Krawitt EL. Autoimmune hepatitis: classification, heterogeneity, and treatment. Am J Med. 1994;96:23S-26S.
5. Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev. 2000;174:250-259.
6. Doherty DG, Donaldson PT, Underhill JA, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology. 1994;19:609-615.
7. Czaja AJ, Strettell MD, Thomson LJ, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 1997;25:317-323.
8. Vazquez-Garcia MN, Alaez C, Olivo A, et al. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol. 1998;28:985-990.
9. Pando M, Larriba J, Fernandez GC, et al. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology. 1999;30:1374-1380.
10. Ma X, Qiu DK. Relationship between autoimmune hepatitis and HLA-DR4 and DR: a allelic sequences in the third hypervariable region in Chinese. World J Gastroenterol. 2001;7:1-6.
11. Seki T, Ota M, Furuta S, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology. 1992;103:1041-1047.
12. Bittencourt PL, Goldberg AC, Cancado EL, et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol. 1999;94:1906-1913.
13. Goldberg AC, Bittencourt PL, Mougin B, et al. Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus. Hum Immunol. 2001;2:165-169.
14. Djilali-Saiah I, Renous R, Caillat-Zucman S, et al. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J Hepatol. 2004;40:904-909.
15. Czaja AJ, Kruger M, Santrach PJ, et al. Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol. 1997;92:2197-2200.
16. Cookson S, Constantini PK, Clare M, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology. 1999;30:851-856.
17. Agarwal K, Czaja AJ, Jones DE, et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology. 2000;31:49-53.
18. Bittencourt PL, Palácios SA, Caņado ELR, et al. Autoimmune hepatitis types 1 and 2 in Brazil is not associated with polymorphisms in tumor necrosis factor α polymorphisms. J Hepatol. 2001;35:24-28.
19. Bittencourt PL, Palacios SA, Cancado EL, et al. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am J Gastroenterol. 2003;98:1616-1620.
20. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 1997;25:541-547.
21. Czaja Aj, Carpenter HA, Santrach PJ, et al. Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology. 1993;18:816-822.
22. Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol. 2002;97:2051-2057.
23. Marcos Y, Fainboim HA, Capucchio M, et al. Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis. Hepatology. 1994;19:1371-1374.
24. Homberg JC, Abuaf N, Bernard O, et al. Chronic active associated with antiliver/kidney microsome antibody type 1: a second type of "Autoimmune" Hepatitis. Hepatology. 1987;7:1333-1339.
25. Czaja AJ, Souto EO, Bittencourt PL, et al. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol. 2002;37:302-308.
26. Czaja AJ, Carpenter HA, Santrach PJ, et al. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology. 1993;105:1502-1507.
27. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929-938.
28. Cançado ELR, Vilas-Boas LS, Abrantes-Lemos CP, et al. Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture. Hepatology. 1996;23:1098-1104.
29. Abuaf N, Johanet C, Chretien P, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology. 1982;16:892-898.
30. Alvarez F, Bernard O, Homberg JC, et al. Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med. 1985;161:1231-1236.
31. Cordoner-Franch P, Paradis K, Gueguen M, et al. A new antigen recognized by anti-liver-kidney-microsome antibody (LKMA). Clin Exp Immunol. 1989;75:354-358.
32. Gustincich S, Mamfioletti G, Delsal G, et al. A fast method for high-quality genomic DNA extraction from whole human blood. Bio Techniques. 1991;11:298-302.
33. Goldberg AC, Chiarella JM, Marin MLC, et al. Molecular typing of HLA class II antigens in the São Paulo population. Genetics Mol Biol. 1998;21:1-5.
34. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donorrecipient matching in cadaveric transplantations. Tissue Antigens. 1992;39:225-235.
35. Wilson AG, di Giovine FS, Blakemore AIF, et al. Single base polymorphism in the human tumor necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1:353.
36. Fukuda K, Sugawa K, Wakisaka A, et al. Statistical detection of HLA and disease association. Tissue Antigens. 1985;26:81-86.
37. Czaja AJ, Strettell MD, Thomson LJ, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 1997;25:317-323.
38. Onji M, Nonaka T, Horiike N, et al. Present status of autoimmune hepatitis in Japan. Gastroenterol Jpn. 1993;28:134-138.
39. Nishioka M. Autoimmune hepatitis in Asia. In: Manns MP, Paumgartner G, Leuschner U, eds. Immunology and the Liver. Falk Symposium 114. Dordrecht: Kluwer Academic Publishers; 2000:69-81.